The partnership marks Insempra’s first lipid product to reach global markets, with further bio-based ingredients to follow under a broader strategic collaboration.

We are pleased to announce an exclusive global distribution agreement with Brenntag, the global market leader in chemicals and ingredients distribution, to bring our innovative Omega-7 biolipid to Beauty & Personal Care markets worldwide.

The product will be available globally through Brenntag’s Beauty & Personal Care division under the name CosVivet™ ActiLipid O7, a next-generation biotech biolipid that combines active performance, multifunctionality, and sustainability in a single ingredient.

A biolipid built for modern formulations

CosVivet™ ActiLipid O7 is based on Insempra’s proprietary Omega-7 biolipid, developed using our precision fermentation platform. Rich in omega-7, it has been designed to support moisturisation and help maintain smooth, supple-looking skin — making it particularly suitable for sensitive and delicate skin care applications.

The ingredient delivers a refined sensory profile: silky, lightweight, and non-greasy, with effortless spreadability and an elegant finish. It is fully oil-soluble, compatible with lipophilic raw materials, and offers formulation flexibility across a wide range of skin care concepts. As a clear yellow liquid with minimal odour, it has high thermal stability and minimal impact on the odour and colour of finished formulations.

For brands seeking sustainable alternatives to oils like sea buckthorn and macadamia, without the variability issues and associated drawbacks of agricultural sourcing, CosVivet™ ActiLipid O7 offers a consistent, scalable solution produced via precision fermentation.

Brenntag’s global distribution network, deep technical expertise, and commitment to sustainable innovation make them the right partner to bring this product and the innovations that will follow to market at scale. Their Innovation and Application Centers offer the kind of formulation support that helps customers evaluate and adopt new ingredients effectively.

“This distribution agreement with Brenntag represents a pivotal moment for Insempra as we scale our biotechnology innovations to reach the global beauty industry,” said Jens Klein, CEO and Founder of Insempra. “Brenntag’s unparalleled market reach, deep technical expertise, and commitment to sustainability make them the ideal partner to bring our Omega-7 biolipid and future products to market.”

“This is only the beginning — we are already developing additional breakthrough ingredients that will continue to transform the beauty and personal care industry.”

The first of many

This agreement is the first product under a broader strategic collaboration between Insempra and Brenntag. With a growing pipeline of bio-based ingredients — spanning lipids, actives, and multifunctionals — we are steadily expanding the range of high-performance, sustainable alternatives available to the beauty and personal care industry.

CosVivet™ ActiLipid O7 will be officially launched at in-cosmetics Global in Paris, April 14–16, 2026.

→ Visit Insempra at Stand 1F 93 (Sustainability Hall)
→ Join the presentation ‘Next-generation fermented biolipid for advanced beauty performance and environmental responsibility’ at the Sustainability Zone Theatre, Hall 7, Level 1 — Wednesday, April 15, 13:45–14:15 (Brenntag booth 1C100)

To learn more about CosVivet™ ActiLipid O7 or to set up a meeting at in-cosmetics, contact Giovanni Salerno (giovanni.salerno@insempra.bio) or Alina Strehle (alina.strehle@insempra.bio).

Insempra is an industrial biotechnology company enabling industries to create superior products in harmony with nature. By combining advanced bioscience with scalable manufacturing technologies, Insempra delivers high-performance specialty ingredients through precision fermentation. For decades, industries have relied on chemical production processes and petrochemical-derived inputs, depleting our planet’s limited resources. Insempra is driving the shift toward industrial-scale bio-manufacturing – combining supply chain resilience while reducing environmental impact. With a multidisciplinary team of biologists, engineers, and entrepreneurs, Insempra is building the next generation of specialty ingredient manufacturing.  For more information, visit www.insempra.bio.

Media contact Insempra GmbH, Munich Press and media enquiries: Nicole Laurence, nicole.laurence@insempra.bio

Posted by Nicole Laurence